Literature DB >> 19729442

Posing the question again: does chronic uric acid nephropathy exist?

Orson W Moe1.   

Abstract

The question of whether hyperuricemia can induce chronic direct renal injury has been argued for many decades. Despite continued efforts and strong motivations to seek an answer, the current evidence still cannot definitively prove or refute the hypothesis. Recent data in rodents do favor causality between hyperuricemia and renal disease. Human epidemiologic data are quite varied, but positive studies do exist. Pathophysiologic models of biology for this entity are sparse in animals and nonexistent in humans.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19729442      PMCID: PMC4473252          DOI: 10.1681/ASN.2008101115

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  12 in total

1.  Hyperuricemia; relationship to hypercholesteremia and acute myocardial infarction.

Authors:  P M KOHN; G B PROZAN
Journal:  J Am Med Assoc       Date:  1959-08-15

2.  THE ENVIRONMENT AND DISEASE: ASSOCIATION OR CAUSATION?

Authors:  A B HILL
Journal:  Proc R Soc Med       Date:  1965-05

3.  [Tuberculosis etiology].

Authors:  R KOCH
Journal:  Dtsch Gesundheitsw       Date:  1952-04-10

4.  Requiem for gouty nephropathy.

Authors:  L H Beck
Journal:  Kidney Int       Date:  1986-08       Impact factor: 10.612

Review 5.  Role of uric acid in hypertension, renal disease, and metabolic syndrome.

Authors:  Marcelo Heinig; Richard J Johnson
Journal:  Cleve Clin J Med       Date:  2006-12       Impact factor: 2.321

Review 6.  Urate nephropathy.

Authors:  R J Foley; E J Weinman
Journal:  Am J Med Sci       Date:  1984-12       Impact factor: 2.378

7.  Epidemiology of gout and hyperuricemia. A long-term population study.

Authors:  A P Hall; P E Barry; T R Dawber; P M McNamara
Journal:  Am J Med       Date:  1967-01       Impact factor: 4.965

8.  Renal function in gout. IV. An analysis of 524 gouty subjects including long-term follow-up studies.

Authors:  L Berger; T F Yü
Journal:  Am J Med       Date:  1975-11       Impact factor: 4.965

Review 9.  Uric acid and cardiovascular disease: a renal-cardiac relationship?

Authors:  B F Culleton
Journal:  Curr Opin Nephrol Hypertens       Date:  2001-05       Impact factor: 2.894

10.  Impaired renal function gout: its association with hypertensive vascular disease and intrinsic renal disease.

Authors:  T F Yü; L Berger
Journal:  Am J Med       Date:  1982-01       Impact factor: 4.965

View more
  8 in total

1.  The association between elevated serum uric acid level and an increased risk of renal function decline in a health checkup cohort in China.

Authors:  Xia Cao; Liuxin Wu; Zhiheng Chen
Journal:  Int Urol Nephrol       Date:  2017-11-01       Impact factor: 2.370

2.  Cause-Specific Mortality in Patients with Gout in the United States Veteran's Health Administration: A Matched Cohort Study.

Authors:  Lindsay N Helget; Bryant R England; Punyasha Roul; Harlan Sayles; Alison D Petro; Tuhina Neogi; James R O'Dell; Ted R Mikuls
Journal:  Arthritis Care Res (Hoboken)       Date:  2022-03-16       Impact factor: 5.178

3.  Impact of non-adherence on the safety and efficacy of uric acid-lowering therapies in the treatment of gout.

Authors:  Daniel Hill-McManus; Elena Soto; Scott Marshall; Steven Lane; Dyfrig Hughes
Journal:  Br J Clin Pharmacol       Date:  2017-10-10       Impact factor: 4.335

4.  Hyperuricemia and its related histopathological features on renal biopsy.

Authors:  Shulei Fan; Ping Zhang; Amanda Ying Wang; Xia Wang; Li Wang; Guisen Li; Daqing Hong
Journal:  BMC Nephrol       Date:  2019-03-18       Impact factor: 2.388

5.  Uric Acid and Impairment of Renal Function in Non-diabetic Hypertensive Patients.

Authors:  Yi-Hsin Hung; Chin-Chou Huang; Liang-Yu Lin; Jaw-Wen Chen
Journal:  Front Med (Lausanne)       Date:  2022-01-24

6.  The Effects of Febuxostat on Urine NGAL and Urine KIM-1 in Patients with Hyperuricemia.

Authors:  Yushang Tang; Tongqiang Liu; Qiuping Cai; Minwen Zhao
Journal:  J Healthc Eng       Date:  2022-04-04       Impact factor: 2.682

7.  Renoprotective effects of febuxostat compared with allopurinol in patients with hyperuricemia: A systematic review and meta-analysis.

Authors:  Sollip Kim; Hyun-Jung Kim; Hyeong-Sik Ahn; Se Won Oh; Kum Hyun Han; Tae-Hyun Um; Chong-Rae Cho; Sang Youb Han
Journal:  Kidney Res Clin Pract       Date:  2017-09-30

Review 8.  Management of Hyperuricemia in Patients with Chronic Kidney Disease: a Focus on Renal Protection.

Authors:  Jan T Kielstein; Roberto Pontremoli; Michel Burnier
Journal:  Curr Hypertens Rep       Date:  2020-10-31       Impact factor: 5.369

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.